371 related articles for article (PubMed ID: 15721360)
1. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
2. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
Arsenio J; Deschambault Y; Cao J
Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
[TBL] [Abstract][Full Text] [Related]
3. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.
Langland JO; Jacobs BL
Virology; 2004 Jul; 324(2):419-29. PubMed ID: 15207627
[TBL] [Abstract][Full Text] [Related]
6. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.
Brandt TA; Jacobs BL
J Virol; 2001 Jan; 75(2):850-6. PubMed ID: 11134298
[TBL] [Abstract][Full Text] [Related]
7. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.
Shors T; Kibler KV; Perkins KB; Seidler-Wulff R; Banaszak MP; Jacobs BL
Virology; 1997 Dec; 239(2):269-76. PubMed ID: 9434718
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
Price N; Tscharke DC; Hollinshead M; Smith GL
Virology; 2000 Feb; 267(1):65-79. PubMed ID: 10648184
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
12. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
13. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
Parkinson JE; Sanderson CM; Smith GL
Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
[TBL] [Abstract][Full Text] [Related]
14. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
Gurt I; Abdalrhman I; Katz E
Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
[TBL] [Abstract][Full Text] [Related]
16. Reintroduction of gene(s) into an attenuated deletion mutant of vaccinia virus strain IHD-W.
Chang PY; Pogo BG
Microb Pathog; 1993 Nov; 15(5):347-57. PubMed ID: 8015416
[TBL] [Abstract][Full Text] [Related]
17. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
Xiang Y; Condit RC; Vijaysri S; Jacobs B; Williams BR; Silverman RH
J Virol; 2002 May; 76(10):5251-9. PubMed ID: 11967338
[TBL] [Abstract][Full Text] [Related]
18. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.
Vijaysri S; Talasela L; Mercer AA; Mcinnes CJ; Jacobs BL; Langland JO
Virology; 2003 Sep; 314(1):305-14. PubMed ID: 14517083
[TBL] [Abstract][Full Text] [Related]
19. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
[TBL] [Abstract][Full Text] [Related]
20. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
